ZYDUSLIFE Zydus Lifesciences Ltd Investor Conferences Announcement 2025 - Investor Presentation Zydus Lifesciences Ltd provided an Investor Presentation detailing strong financial results for FY25, with total revenues up 18% YoY, a net profit increase of 18%, and an EBITDA margin of 32.6%. The presentation also noted a successful inspection of their Ambernath API facility with no observations..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd